Sound Pharmaceuticals, Inc. (SPI) is developing therapeutics that will enable doctors and patients to prevent and treat various forms of hearing loss. Sensorineural hearing loss is the third largest disease in the industrialized world and affects 50 million Americans. Estimates from the NIH and the CDC place the total annual costs of hearing loss at approximately $50 billion per year in the U.S. alone.
View Top Employees from Sound Pharmaceuticals, Inc.Website | http://www.soundpharmaceuticals.com |
Revenue | $4 million |
Employees | 14 (7 on RocketReach) |
Founded | 2001 |
Address | 4010 Stone Way N Ste 120, Seattle, Washington 98103, US |
Phone | (206) 634-2559 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Biotechnology, Retail, Science and Engineering, Health Care, Pharmaceutical |
Web Rank | 12 Million |
Keywords | Cra Handle Mutiple Site With Supply |
Competitors | ARCA biopharma, Inc., Affectis Pharmaceuticals, Karus Therapeutics Limited, Neuraltus Pharmaceuticals, SENSORION |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Sound Pharmaceuticals, Inc. employee's phone or email?
The Sound Pharmaceuticals, Inc. annual revenue was $4 million in 2024.
7 people are employed at Sound Pharmaceuticals, Inc..
Sound Pharmaceuticals, Inc. is based in Seattle, Washington.
The NAICS codes for Sound Pharmaceuticals, Inc. are [325, 32, 32541, 3254].
The SIC codes for Sound Pharmaceuticals, Inc. are [283, 28].